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Background: Anaerotruncus colihomonis is a newly described bacterial genus and species isolated from
the stool specimens of children. Its clinical significance, however, is unknown.
Aims: To describe a case of A colihominis bacteraemia identified by 16S ribosomal RNA (rRNA) gene
sequencing and provide an emended description of the species.
Methods: An unidentified anaerobic bacillus (strain HKU19) that stains Gram negative was subjected to
characterisation by 16S rRNA gene sequencing, G+C content determination and electron microscopy.
Results: Strain HKU19 was isolated from the blood culture of a 78-year-old woman with nosocomial
bacteraemia. It was found to be an anaerobic, non-motile, pleomorphic, thin bacillus that stains Gram
negative. It produces Indole and utilises glucose and mannose. Identifying the strain to the species level
was not possible by conventional phenotypic tests and commercial identification systems. The G+C content
of strain HKU19 was found to be 53.43 mol%. A similarity of 99.3% nucleotide identities was found
between the 16S rRNA gene sequence of strain HKU19 and that of A colihominis WAL 14 565T, which
was isolated from a human faecal specimen. In contrast with the original description of A colihominis,
HKU19 was found to produce occasional oval, terminal spores, although the other phenotypic
characteristics matched. Spores were also occasionally observed when the two previously reported
strains were re-examined.
Conclusions: Although the source of the bacteraemia in the patient cannot be determined, this report
suggests that A colihominis is of clinical significance. Spore formation is proposed as an emended
description of A colihominis.
T
he identification of anaerobic Gram-positive bacilli is
often difficult in clinical microbiology laboratories.
Firstly, spore formation is sometimes not obvious in
bacterial isolates recovered directly from clinical specimens.
Secondly, identification of bacilli by commercial kits, or
analysis of cell wall fatty acids and metabolic end products by
gas–liquid chromatogaphy, is difficult because of the limited
database and a lack of special equipment and expertise.
Thirdly, despite having Gram-positive cell walls, certain
species, including many Clostridium species, often stain as
Gram negative. As a result, the epidemiology and pathogenic
potential of many members of this group of bacteria have
been poorly understood. Since the recognition of the 16S
ribosomal RNA (rRNA) gene as a new standard for
classification and identification of bacteria,1 2 their classifica-
tion has been revised and many new species identified.3–6
Anaerotruncus is a newly described bacterial genus in which
A colihominis is the only species.7 The bacterium was first
identified by phenotypic and phylogenetic studies on two
isolates of an unidentified Gram-positive, anaerobic bacillus
isolated from the stool specimens of two children. Owing to
its loose phylogenetic association with, and phenotypic
difference to, its closest relatives within the C leptum rRNA
cluster, and, more importantly, the absence of spore
formation, it was classified as a distinct genus and species.
It is not known, however, whether the bacterium is only part
of the human gut flora or whether it can be associated with
disease. In this study, we describe the identification of an
anaerobic Gram-positive bacillus associated with nosocomial
bacteraemia by a combination of phenotypic and genotypic
tests, including 16S rRNA gene analysis. Although the
bacterium was able to produce spores, it is most likely to be
a strain of A colihominis by phylogenetic analysis. On the basis
of our findings, we propose an emended description of the
species.
METHODS
Microbiological methods
Clinical data were collected prospectively. Clinical specimens
were collected and handled according to standard protocols.
The BACTEC 9240 blood culture system (Becton Dickinson,
Maryland, USA) was used. The isolate was identified by a
combination of standard conventional biochemical meth-
ods8 9 and the Vitek (ANI; bioMerieux Vitek, North Carolina,
USA), API (20A; bioMerieux Vitek, Hazelwood, Missouri,
USA) and ATB Expression (rapid ID32A; bioMerieux Vitek,
USA) systems. Antimicrobial susceptibility was tested by the
E-test (AB Biodisk, Solna, Sweden) on Brucella blood agar
plates and the results were interpreted according to the
NCCLS criteria for anaerobic bacteria.10 All tests were carried
out in triplicate, with freshly prepared media on separate
occasions.
Scanning electron microscopy
Scanning electron microscopy (SEM) was carried out as
described in our previous publications.11 12 Briefly, bacterial
cells were settled onto a polycarbonate membrane
(Nucleopore) for fixing in 2.5% glutaraldehyde. Critical dried
material was coated with palladium in a BAL-TEC SCD 005
SEM coating system and examined under a Leica Cambridge
Abbreviations: rRNA, ribosomal RNA; SEM, scanning electron
microscopy; Tm, melting temperature; PCR, polymerase chain reaction;
rRNA, ribosomal RNA
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Stereoscan 440 scanning electron microscope operating at
12 kV.
16S rRNA gene sequencing and phylogenetic
characterisation
Bacterial DNA extraction, PCR amplification and DNA
sequencing of the 16S rRNA gene of HKU19 were carried
out with polymerase chain reaction (PCR) primers (LPW57
59-AGTTTGATCCTGGCTCAG-39 and LPW205 59-CTTGTTACG
ACTTCACCC-39) and additional sequencing primers
(LPW104 59-ACTCCTACGGGAGGCAGCAGTA-39 and
LPW306 59-TGAGATGTTGGGTTAAGT-39; Gibco BRL,
Rockville, Maryland, USA), as described previously.13 14 The
sequences of the PCR products were compared with known
16S rRNA gene sequences in the GenBank (http://
www.ncbi.nlm.nih.gov) by multiple sequence alignment with
the Clustal W program.15 The phylogenetic tree was con-
structed using Clustal X V.1.8116 and the neighbour-joining
method with GrowTree (Genetics Computer Group, San
Diego, USA).
G+C content determination
The genomic DNA G+C content was determined by thermal
denaturation according to previously published protocols.12 17
Briefly, the temperature of the genomic DNA in standard
sodium citrate (0.15 M NaCl with 0.015 M sodium citrate)
buffer (25 mg/ml) was increased slowly (0.5 C˚/min) from
25 C˚ and the absorbance of the solution at 260 nm was
monitored continuously against a blank containing only
standard sodium citrate buffer. The melting temperature
(Tm) of the DNA is defined as the temperature at 50%
hyperchromicity. The G+C content of the genomic DNA was
calculated by the formula (G+C)% = 2.44Tm2169.18
Nucleotide sequence accession number
The 16S rRNA gene sequence of HKU19 has been lodged in
the GenBank sequence database under the accession number
DQ002932.
RESULTS AND DISCUSSION
Patient
A 78-year-old woman was admitted to hospital because of
acute exacerbation of chronic obstructive airway disease. She
also had ischaemic heart disease, hypertension and gout. She
was put on prolonged mechanical ventilation because of
respiratory failure and secondary pneumothorax, which
resolved gradually with chest drain. During the fifth week
of hospitalisation, she developed fever, with no localised
symptoms or signs. Her total leucocyte count was 17.186109/l
(neutrophils 14.116109/l, lymphocytes 1.426109/l, monocytes
1.116109/l and basophils 0.156109/l), haemoglobin level
10 g/dl and platelet count 4196109/l. The renal and liver
function tests were within normal limits. Blood culture was
performed. Empirical intravenous cefoperazone/sulbactam
and metronidazole were started. On day 2 post-incubation,
the anaerobic blood culture bottle turned positive with a pure
culture of a pleomorphic, thin bacillus that stained Gram
negative (strain HKU19). Subsequently, no bacteria were
grown from repeated blood cultures. No infection was
evident and the patient responded to antibiotics. Her
condition was subsequently complicated by episodes of
nosocomial pneumonia and gastrointestinal bleeding asso-
ciated with steroid treatment over the next few weeks. The
patient ultimately survived after 3 months of hospitalisation.
Phenotypic characteristics
Strain HKU19 grew on sheep blood agar as non-haemolytic,
irregularly edged, grey colonies 2–3 mm in diameter after
48 h of incubation at 37 C˚ in an anaerobic environment. It
did not grow in ambient air, ambient air supplemented with
5% CO2 or microaerophilic conditions. Cells formed occa-
sional oval terminal endospores, producing a drumstick-like
appearance (fig 1A). The strain was non-motile. It did not
produce catalase or reduce nitrate and failed to hydrolyse
aesculin, gelatin or urea. It produced indole and b-gluocosi-
dase, and used glucose and mannose but not arabinose,
cellobiose, glycerol, lactose, maltose, mannitol, melezitose,
raffinose, rhamnose, salicin, sorbitol, sucrose, trehalose or
xylose. Glucose was fermented, with the production of acid
and gas. Lysine arylamidase was detected by the Vitek ANI
system. The Vitek ANI system showed that it was ‘‘uni-
dentified’’, whereas the API system (20A) (code profile
50404003) showed a match of 83.9% to Closfridium cadaveris
and 15.5% to C bifermentans, and the ATB Expression system
(ID32A; code profile 0010200000) showed a 75% match to C
bifermentans, 17% to Fusobacterium nucleatum and 6% to
Clostridium tetani. Analysis of metabolic end products by
gas–liquid chromatogaphy from peptone–yeast–glucose broth
yielded only acetic and butyric acids, but no organic acids.
The isolate was sensitive to vancomycin (5 mg), but resistant
to colistin (10 mg) identification discs. The minimum
inhibitory concentrations of penicillin, cefotaxime, vancomy-
cin and metronidazole were 0.094, 0.047, 0.5 and ,0.016 mg/
ml, respectively.
A
B
Figure 1 Spore stain of HKU19 (A) showing terminal spores (green)
with a drumstick-like appearance. Scanning electron micrograph of
HKU19 (B) (size bar 2 mm). Bacterial cells were bacilli, which multiplied
by longitudinal division.
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SEM
SEM showed that bacterial cells of HKU19 were bacilli
(0.56225 mm), which multiplied by longitudinal division
(fig 1B).
16S ribosomal RNA gene sequencing, G+C content
and phylogenetic characterisation
As conventional phenotypic tests and commercial identifica-
tion kits failed to ascertain the identity of HKU19, its 16S
rRNA gene was amplified and sequenced. PCR of the 16S
rRNA gene showed a band at about 1400 bp. The 16S rRNA
gene sequence of strain HKU19 had a 0.7% nucleotide
difference from that of A colihominis (GenBank accession
number AJ315980); a 10.2% nucleotide difference from that
of Acetanaerobacterium elongatum (GenBank accession number
AY487928); a 10.5% difference from that of A elongatum
(GenBank accession number AY518589); a 11.5% difference
from that of C methylpentosum (GenBank accession number
Y18181); and a 12.5% difference from that of C cellulosi
(GenBank accession number L09177; fig 2). The G+C content
of strain HKU19 (mean (SD)) was 53.43 (1.09) mol%. On the
basis of phylogenetic affiliation, HKU19 is a strain of A
colihominis, which belongs to the C leptum suprageneric rRNA
cluster. Table 1 summarises a comparison between the
characteristics of HKU19 and the type strain of A colihominis,
WAL 14 565T.
The present isolate was probably more clinically important
than a contaminant because of its association with an acute
febrile illness, leucocytosis, the absence of other infective foci
and the patient’s prompt response to antibiotics. The source
of the bacteraemia was, however, unknown. The patient did
not have any gastrointestinal tract disease nor had she
undergone gut instrumentation. Further studies with 16S
rRNA gene sequencing to characterise more clinical isolates
of unidentified anaerobic Gram-positive bacilli may help
better understand the epidemiology and pathogenic potential
of this bacterium.
Spore formation was also evident in the two A colihominis
strains reported previously.7 Unlike HKU19, the originally
described A colihominis strains were non-spore forming. After
the recognition of spore formation in the strain in this study,
the two recently reported strains of A colihominis were
re-examined by both malachite green stain and phase
contrast microscopy. They were also found to form occasional
spores after incubation on anaerobic blood agar for 5 days. As
a result, we have written an emended description of this
species.
Emended description of A colihominis
This description is based on three strains, including the type
strains WAL 14 565T and HKU19.7 Cells are Gram-positive,
thin rods of approximately 0.56225 mm, that form oval,
terminal spores. After 48 h of anaerobic incubation at 37 C˚
under an N2/CO2 (80:20, v/v) gas phase, colonies were 2–
3 mm in diameter, grey, entire-edged, irregularly shaped, low
pyramidal in profile and translucent. The pH range for
growth is 5.5–11 and the growth temperature range is 36–
40 C˚. The cells are catalase negative; nitrate is not reduced to
nitrite, but indole is produced. The end products of
metabolism from peptone–yeast broth are acetic and butyric
acids. Aesculin, gelatin and urea are not hydrolysed. They are
able to grow in peptone–yeast broth supplemented with 1%
glucose, fructose, mannose or cellobiose, but they do not
grow in peptone–yeast broth alone or peptone–yeast broth
supplemented with arabinose, inositol, lactose, maltose,
mannitol, melezitose, melibiose, raffinose, rhamnose, ribose,
salicin, sorbitol, starch or xylose. With the Biolog system, N-
acetyl-D-glucosamine, N-acetyl-b-D-mannosamine, arbutin,
D-cellobiose, dextrin, D-fructose, D-galactose, D-galacturonic
acid, a-D-glucose, maltose, maltotriose, D-mannose, methyl-
3-D-glucose, methyl-b-D-glucose, methyl-b-D-galactoside,
methyl-b-D-glucoside, palatinose, D-trehalose and turanose
are used. a-Ketobutyric acid, a-ketovaleric acid, L-malic acid,
pyruvic acid and pyruvic acid methyl ester are also used.
Serine, L-valine, 29-deoxyadenosine, inosine, thymidine and
uridine are used for growth. With the API ZYM and Rapid ID
32A systems, acid phosphatase and indole activities are
detected, but N-acetyl-b-glucosaminidase, alanine arylami-
dase, alkaline phosphatase, arginine arylamidase, arginine
dehydrolase, a-arabinosidase, ester lipase C8, a-galactosi-
dase, b-galactosidase, a-glucosidase, b-glucuronidase, gluta-
myl glutamic acid arylamidase, a-mannosidase, a-fucosidase,
chymotrypsin, alanine arylamidase, leucyl glycine arylami-
dase, phosphoamidase, trypsin, cystine arylamidase, esterase
Atopobium minutum (X67148)
Clostridium cellulosi (L09177)
HKU19 
Anaerotruncus colihominis (AJ315980)
Acetanaerobacterium elongatum (AY487928)
Acetanaerobacterium elongatum (AY518589)
1000
Anaerofilum agile (X98011) 
Anaerofilum pentosovorans (X97852)
Eubacterium siraeum (L34625)
1000
Ruminococcus flavefaciens (X85097)
Ruminococcus flavefaciens (AF030446) 
Ruminococcus callidus (X85100)
1000
Ruminococcus albus (X85098)
998
Clostridium methylpentosum (Y18181)
Clostridium leptum (AJ305238)
Clostridium sporosphaeroides (X66002)
Ruminococcus bromii (X85099)
1000
881
795
734
592
406
927
387
953
0.01
1000
Figure 2 Phylogenetic tree showing the relationships of strain HKU19 to Anaerotruncus colihominis (Genbank accession number AJ315980) and
members of other related genera. The tree was constructed by the neighbour-joining method and bootstrap values calculated from 1000 trees. A total
of 1419 nucleotide positions were included in the analysis. The scale bar indicates the estimated number of substitutions per 100 bases using the Jukes–
Cantor correction. Names and accession numbers are given as cited in the GenBank database.
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C4, b-galactosidase-6-phosphate, glutamic acid decarboxylase,
glycine arylamidase, histidine arylamidase, lipase C14, leucine
arylamidase, phenylalanine arylamidase, proline arylamidase,
pyroglutamic acid arylamidase, serine arylamidase, tyrosine
arylamidase and valine arylamidase activities are not detected.
Cells are sensitive to vancomycin (5 mg) and kanamycin
(1000 mg), but resistant to colistin sulphate (10 mg) identifica-
tion discs. DNA G+C content is 53–54 mol%. The organism is
isolated from human clinical specimens. The type strain is WAL
14 565T = CCUG 45 055T = CIP 107 765T.
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